Products

5-Bromo-4-fluoro-1-methyl-1H-indazole (CAS 1784678-61-0) is a halogenated indazole derivative featuring a fused bicyclic scaffold composed of a benzene ring and a pyrazole ring, with bromine and fluorine substituents at the 5- and 4-positions respectively, and a methyl group at the N1 position .

Crisaborole (CAS 906673-24-3) is a boron-containing, non-steroidal topical phosphodiesterase 4 (PDE4) inhibitor. The molecule features a benzoxaborole core—a boron atom incorporated into a five-membered oxaborole ring fused to a benzene ring—substituted with a 4-cyanophenoxy group.

Rivaroxaban (CAS 366789-02-8) is an orally active, direct Factor Xa inhibitor. The molecule features an oxazolidinone core with a morpholinone substituent and a chlorothiophene carboxamide side chain. This structural arrangement enables Rivaroxaban to directly inhibit Factor Xa, blocking the amplification of the coagulation cascade and thrombin generation.

Ropivacaine Hydrochloride (CAS 132112-35-7) is the hydrochloride monohydrate salt of (S)-ropivacaine, a long-acting amide-type local anesthetic. The molecule features a piperidine ring with an N-propyl substituent and a 2,6-dimethylphenylcarboxamide group.

Atracurium Besylate (CAS 64228-81-5) is a non-depolarizing neuromuscular blocking agent of the benzylisoquinolinium class. The molecule consists of two quaternary isoquinolinium moieties linked by a pentamethylene diester chain. This structural arrangement enables Atracurium Besylate to competitively antagonize acetylcholine at the nicotinic receptor of the motor endplate, producing skeletal muscle relaxation.

Cisatracurium Besylate (CAS 96946-42-8) is a non-depolarizing neuromuscular blocking agent and the single (1R,1'R) stereoisomer of atracurium. The molecule consists of two quaternary isoquinolinium moieties linked by a pentamethylene diester chain, with defined (1R,1'R) stereochemistry.